recall
saveASTRAZENECA PHARMACEUTICALS recall (Cls II)
community read0 votes
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30 — Reason: Lack of Assurance of Sterility: — Status: Ongoing
view source ↗Data sources
last refreshed 33m ago
Found something off?
same company · ±60 days · 6
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalOct 20, 2025
- approvaltezepelumab: TEZSPIRE (TEZEPELUMAB-EKKO) — FDA approvalOct 17, 2025
- approvalcapivasertib: TRUQAP (CAPIVASERTIB) — FDA approvalNov 14, 2025
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB) — FDA approvalNov 19, 2025
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB SULFATE) — FDA approvalNov 19, 2025
- approvalIMFINZI (DURVALUMAB) — FDA approvalNov 25, 2025
🐶 often sniffed alongside
top 8- tagOncology15 co-mentions · 4 sources
- tagNephrology3 co-mentions · 1 sources
- tagNeurology3 co-mentions · 1 sources
- tagPsychiatry & CNS3 co-mentions · 1 sources
- tagBreast Cancer2 co-mentions · 1 sources
- tagCOPD2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 2 sources
- tagPulmonology2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that